The Gym Group Expands Amid Surge in Weight-Loss Jab Popularity

The Gym Group is capitalizing on the rising popularity of weight-loss injections, reporting strong business growth as a result. According to Will Orr, chief executive of the low-cost gym chain, the company is “absolutely” experiencing a positive impact from the increased usage of GLP-1 medications. He described this trend as a “tailwind and contributory factor” for the business, seeing it as an opportunity to assist individuals in maintaining the weight loss achieved through these treatments.

Recent studies from the University of Oxford and University College London have highlighted the importance of ongoing support for individuals using fat-loss injections. While the University of Oxford noted that people need continued guidance on diet and exercise to prevent regaining weight, research from the London institutions indicated that those using these injections might face risks of muscle loss. Orr emphasized that building strength in the gym is vital, as “GLP-1s can reduce muscle density.”

Growth and Expansion Plans

Analysts at Peel Hunt have identified GLP-1 medications and a growing focus on fitness among Gen Z as significant factors driving demand for The Gym Group’s services. The firm has announced plans to open an additional 75 new sites over the next three years, exceeding previous targets. This expansion comes after a report indicated a strong revenue increase, with total revenue rising 8% to £244.9 million for the year ending December 31. Like-for-like revenue grew by 3% year-on-year, while membership increased by 4%, bringing total members from 891,000 to 923,000.

Orr noted that the company sees “significant opportunities ahead in a market with structural growth tailwinds.” He stated that the firm is accelerating its “organically funded rollout” to meet the rising demand for fitness services. Currently, The Gym Group operates 260 sites across the UK, recording approximately 70 million visits annually.

The company attributes much of its growth to the health-conscious attitudes of younger generations, specifically noting that around 40% of its members are from Gen Z. This demographic increasingly views fitness as a necessity, which aligns well with The Gym Group’s value-oriented offerings.

Positive Market Outlook

The Gym Group’s recent trading update has drawn positive reviews from analysts. Jefferies highlighted an “all-round positive performance,” pointing to successful openings, yield progress, and membership gains. They anticipate that this momentum will carry into 2026. The company also reported that it successfully met its target of opening between 14 and 16 sites in 2025, completing 16 openings during the year.

Additionally, The Gym Group has launched a £10 million share buyback program, which will be funded by surplus cash and is expected to conclude by the end of 2026. Orr expressed confidence in the company’s model, stating, “We entered the key new year member recruitment period well prepared, and our high-value, low-cost offering continues to resonate strongly with consumers.”

The Gym Group is set to publish its full-year results on March 11, which is anticipated with interest by investors and industry analysts alike.